CClinicalTrials.gg
CompletedNCT00065975Updated Aug 18, 2006

Physical CAM Therapies for Chronic Low Back Pain

A Phase 2 interventional study of massage therapy and chiropractic in Chronic Low Back Pain, sponsored by National Center for Complementary and Integrative Health (NCCIH). Completed at 2 sites in United States. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2006-08-18.

Sponsored by National Center for Complementary and Integrative Health (NCCIH) · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Study summary

This is a pilot randomized trial intended to evaluate the effectiveness of acupuncture, chiropractic and massage for chronic back pain in older and younger adults.

02

Conditions studied

  • Chronic Low Back Pain

Keywords

  • chronic low back pain
  • acupuncture
  • chiropractic
  • massage therapy
  • CAM therapies
03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

This study's enrollment of 120 is above the median of 60 across 1,941 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

National Center for Complementary and Integrative Health (NCCIH) is the lead sponsor of 218 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

  • Low back pain duration of at least 3 months;
  • Low back pain occurring in the past week;
  • No numbness or tingling in the lower extremities;
  • No pain that radiates to below the knee;
  • No use of massage, chiropractic or acupuncture for any reason in the past year;
  • Able to attend scheduled appointments;
  • Able to hear, read, and understand English;
  • No low back pain surgery in the past 3 years;
  • No unexplained weight loss;
  • No previous vertebral or spinal fractures;
  • No previous non-traumatic bone fractures;
  • No other spinal pathology, including scoliosis, spinal stenosis, osteoporosis, or ankylosing spondylitis;
  • No cancer (except simple skin cancers) in the past 5 years;
  • No pacemakers;
  • No bleeding problems or anticoagulant use;
  • No major organ transplants;
  • No oral corticosteroid use for more than 4 consecutive weeks during the past year;
  • Cannot be pregnant;
  • Must be able to get down to and up from the floor by yourself;
  • Able to walk 2 flat city blocks unassisted;
  • Willing to participate in periodic telephone interviews.
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants

Interventions

  • Proceduremassage therapy
  • Procedurechiropractic
  • Procedureacupuncture
06

Study locations

2 sites
  • Harvard medical school
    Boston, Massachusetts 00000, United States
  • Harvard Vanguard Medical Associates
    Boston, Massachusetts 00000, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 18, 2006, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00065975
Lead sponsor
National Center for Complementary and Integrative Health (NCCIH)
First posted
Aug 5, 2003
Start date
Apr 2002
Completion
Dec 2002
Last update
Aug 18, 2006

Study contacts

David Eisenberg, MD
principal investigator · Harvard Medical School (HMS and HSDM)
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2006. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion